Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions.
- Published In:
- Virus research, 361, 199642 (2025)
- Authors:
- Mashhadi Abolghasem Shirazi, Maryam, Haghighat, Setareh, Nikbakht, Zahra, Salimkia, Elaheh, Kiumarsy, Armity
- Database ID:
- RPEP-12473
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12473APA
Mashhadi Abolghasem Shirazi, Maryam; Haghighat, Setareh; Nikbakht, Zahra; Salimkia, Elaheh; Kiumarsy, Armity. (2025). Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions.. Virus research, 361, 199642. https://doi.org/10.1016/j.virusres.2025.199642
MLA
Mashhadi Abolghasem Shirazi, Maryam, et al. "Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions.." Virus research, 2025. https://doi.org/10.1016/j.virusres.2025.199642
RethinkPeptides
RethinkPeptides Research Database. "Next-generation antiviral peptides: AI-driven design, transl..." RPEP-12473. Retrieved from https://rethinkpeptides.com/research/mashhadi-2025-nextgeneration-antiviral-peptides-aidriven
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.